Chat with a Doctor: Cord Blood Preservation & Bone Marrow Transplant

Wednesday, August 29, 2012, noon (ET)

baby with umbilical cord

Register for Online Chat

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Do you have a question about umbilical cord blood preservation and stems cells for bone marrow transplant? Matt Kalaycio, MD, of Taussig Cancer Institute, will answer your questions about this medical issue during a live webchat Wednesday, August 29, 2012, at noon (ET).

Get answers to your health questions and concerns. It’s easy to be part of our live chat events, led by Cleveland Clinic doctors and health professionals.

Umbilical Cord Blood Preservation and Stem Cells for Bone Marrow Transplant Live Web Chat on August 29

Live Web Chat: noon to 1 p.m. (ET) on August 29, 2012.

Advertising Policy

Register

Featured Expert
Matt Kalaycio, MD

  • Taussig Cancer Institute
  • Hematologic Oncology and Blood Disorders
  • Director, Bone Marrow Transplant Program

Umbilical cord blood (UCB) is a rich source of blood stem cells and has been successfully substituted for adult bone marrow as a source of stem cells for bone marrow transplants.

The success of these transplants have prompted some to recommend that UCB be collected and stored for future use, leading to an industry organized around the collection and storage of UCB. Companies that collect and store UCB advertise their services to expectant parents, offering security against future serious illnesses for a significant fee.

Advertising Policy

Questions for Dr. Kalaycio for this webchat might include:

  • What are the pros and cons of UCB storage and collection?
  • How expensive is it for parents to have their baby’s umbilical cord blood collected and stored for their family’s use?
  • Is collecting umbilical cord blood safe and painless for the baby?
  • Does collecting UCB involve the embryo in any way?

Dr. Matt Kalaycio is Director of the Bone Marrow Transplant Program and the Myeloma Program at Cleveland Clinic Taussig Cancer Institute.

This Health Chat will open on Tuesday, August 28, 2012 to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.